ProCE Banner Activity

Keeping It Simple With Second-Generation INSTIs

Clinical Thought

Historically, initiating or switching ART regimens was an intimidating process, but the advent of second-generation INSTIs has shifted the treatment landscape. Read my commentary on how second-generation INSTIs have changed the traditional dogma of HIV treatment, strategies for their use in patients with archived ARV resistance, and how ART simplification can benefit even individuals who are stable on their current regimens.

Released: October 27, 2023

Share

Faculty

Don E Smith

Don E Smith, MD, FRCP (London) FAChSHM

Senior Staff Specialist
Conjoint Professor
School of Clinical Medicine
University of New South Wales
Albion Centre
Sydney, Australia

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Target Audience

This program is intended for physicians, pharmacists, registered nurses, physician associates, and other healthcare professionals who care for people with HIV infection.

Program Learning Goal

The goal of this program is to improve HCPs’ competence in adopting HIV management strategies that minimize complexity for both providers and patients at key points in the care cascade

Disclosure

Primary Author

Don E Smith, MD, FRCP (London) FAChSHM

Senior Staff Specialist
Conjoint Professor
School of Clinical Medicine
University of New South Wales
Albion Centre
Sydney, Australia

Don Smith, MD: consultant/advisor/speaker: Gilead, ViiV.